HSLV is a good buy right now for a beginner with a long-term horizon and $50,000-$100,000 to invest. The stock has a fresh positive analyst target revision, pre-market strength, and no negative news pressure, which makes it reasonable to enter now rather than wait. Based on the current data, I would lean buy, not hold.
The short-term setup is mixed but acceptable for entry. Pre-market price is 5.97, sitting just above support at 5.756 and below pivot resistance at 6.199. RSI_6 at 39.573 shows the stock is neither oversold nor overbought, while the MACD histogram is negative and still expanding downward, which suggests near-term momentum is weak. However, moving averages are converging, which often signals a potential turning point. Overall, the technical picture is mildly bearish in the very short term but still close enough to support to justify a long-term buy entry.
Canaccord raised the price target sharply to C$14.75 from C$7.75 and maintained a Speculative Buy rating. Pre-market trading is positive with a 1.19% gain. There has been no recent negative news flow, and hedge funds and insiders are both neutral rather than selling aggressively. For a long-term investor, the upgraded analyst outlook is the main positive catalyst.
There is no recent news to drive immediate momentum. Technical momentum is still weak, with a negative and worsening MACD histogram. Insider and hedge fund activity is neutral, so there is no strong confirmation from smart-money buying. No congress trading data or influential figure transactions were reported.
In 2025/Q4, revenue remained at 0, so there is no meaningful sales growth yet. Net income was -4,280,067, which improved 276.59% year over year, and EPS improved to -0.03 from a worse prior level, showing losses are narrowing. Gross margin was 0, consistent with a pre-revenue or early-stage company profile. The latest quarter suggests financial improvement on a loss basis, but the business is still not generating revenue.
Analyst sentiment is constructive and improving. On 2026-03-17, Canaccord raised its price target to C$14.75 from C$7.75 and kept a Speculative Buy rating. That is a clear bullish revision and the strongest Wall Street signal in the dataset. The pro view is that upside potential remains significant, while the con view is that the stock is still speculative and lacks revenue traction.